Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-016030
Filing Date
2021-04-15
Accepted
2021-04-15 21:20:38
Documents
2
Period of Report
2021-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2707
2 EX-24 DOCUMENT attachment1.htm EX-24 5184
  Complete submission text file 0000899243-21-016030.txt   9233
Mailing Address 726 MAIN STREET REDWOOD CITY CA 94063
Business Address 726 MAIN STREET REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Issuer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOMEA FUSION, INC. 726 MAIN STREET REDWOOD CITY CA 94063
Business Address
Stergiopoulos Sotirios (Reporting) CIK: 0001856641 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40335 | Film No.: 21829913